Skip to main content

Table 2 Medication regimens of 47 patients who developed onychopathy

From: A novel predictive factor for the onset time of docetaxel-induced onychopathy: a multicenter retrospective study

Regimen Number Previous regimens
DTX (60-80)/q3w 20 Carboplatin + PTX (3)
Gefitinib (1)
Carboplatin + gemcitabine (1)
DTX (1)
FEC (10)
FP (1)
Vinorelbine (1)
Trastuzumab (1)
XP (1)
DTX (70)/q3w/prednisolone 4 Goserelin (2)
Leuprorelin (1)
Estramustine (1)
S-1 (80)/cisplatin (40)/DTX (40)/q6w 10 None (10)
S-1 (80)/DTX (40)/q3w 3 Cisplatin + irinotecan (1)
S-1 + cisplatin + DTX (1)
None (1)
DTX (30)/qw 1 None (1)
DTX (20-40)/q2w 3 Tamoxifen + goserelin (1)
PTX (1)
None (1)
DTX (35)/qw/estramustine (560) 1 PTX + estramustine (1)
DTX (40)/q3w/carboplatin 4 Carboplatin + PTX (1)
None (3)
Irinotecan (60)/DTX (35)/q2w 1 AP (1)